- Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysDHL is in discussions with multiple major drugmakers who are looking for the logistics company to either take over their sites or access its resources, the company’s supply chain business CEO Hendr…Endpoints · 1mo ago↗ source
- Summit withdraws $500M offering, citing 'market conditions'The current biotech environment can apparently support an industry-record IPO and simultaneously hamper efforts to raise half a billion dollars. Summit Therapeutics ditched plans for a $500 milli…Endpoints · 1mo ago↗ source
- Sensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophyPlus, news about Imaavy. 👂 Sensorion selects one hearing loss program, axes another: The biotech is ending the development of SENS-501 for OTOF-related hearing loss following a “strategic revie…